BlackRock Institutional Trust’s Intersect ENT, Inc XENT Stock Holding History

BlackRock Institutional Trust’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.23M	Sell	597,305 -6,153	-1%	-$79.7K	﹤0.01%	2586
2016 Q3	$9.56M	Buy	603,458 +39,729	+7%	+$598K	﹤0.01%	2360
2016 Q2	$7.29M	Buy	563,729 +86,806	+18%	+$1.36M	﹤0.01%	2483
2016 Q1	$9.06M	Buy	476,923 +25,941	+6%	+$470K	﹤0.01%	2320
2015 Q4	$10.1M	Sell	450,982 -14,722	-3%	-$291K	﹤0.01%	2316
2015 Q3	$10.9M	Buy	465,704 +206,740	+80%	+$5.7M	﹤0.01%	2234
2015 Q2	$7.41M	Buy	258,964 +189,333	+272%	+$4.96M	﹤0.01%	2571
2015 Q1	$1.8M	Buy	69,631 +18,382	+36%	+$420K	﹤0.01%	3163
2014 Q4	$951K	Sell	51,249 -530	-1%	-$9.54K	﹤0.01%	3367
2014 Q3	$803K	Buy	+51,779	New	+$780K	﹤0.01%	3381

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock Institutional Trust's XENT Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Intersect ENT, Inc (XENT) stake by 1% in Q4 2016, selling an estimated $79.7K and leaving 597,305 shares worth $7.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

BlackRock Institutional Trust first reported a position in XENT in Q3 2014 and has held it in 10 quarters since. The position peaked at $10.9M in Q3 2015. 104 funds tracked by Wall St. Rank hold XENT as of Q4 2016.

BlackRock Institutional Trust held 597,305 shares of Intersect ENT, Inc worth $7.23M as of Q4 2016.
BlackRock Institutional Trust sold 6,153 Intersect ENT, Inc shares in Q4 2016, an estimated $79.7K.
Intersect ENT, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2586 holding.
BlackRock Institutional Trust first reported a position in Intersect ENT, Inc in Q3 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Intersect ENT, Inc position peaked at $10.9M in Q3 2015.
104 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.